Lanib 4 Mg (Lenvatinib Mesylate)

Description

About Lanib 4 Mg

Lenvatinib Mesylate INN 4mg is the active ingredient in each Lanib 4mg tablet. The kinase activity of vascular endothelial growth factor receptors is suppressed by lenvatinib. Patients diagnosed with differentiated thyroid cancer, renal cell carcinoma, hepatocellular carcinoma, or endometrial carcinoma may benefit from taking 4 milligrams of lanib once daily.

Dosage

Until the disease worsens, the standard recommendation for taking Lanib 4mg is five tablets daily with food. Put the capsules in your mouth and drink the water. Take this medication exactly as prescribed by your doctor for the best results.

Side Effects

• Hypertension.
• Cardiac dysfunction.
• Hepatotoxicity.
• Proteinuria.
• diarrhea.

Storage

Keep Lanib 4mg in a cool (below 30 degrees Celsius), dry, dark place (no direct sunlight), and out of the reach of children.